Equities
Basic MaterialsChemicals
  • Price (BRL)19.10
  • Today's Change-0.69 / -3.49%
  • Shares traded5.15m
  • 1 Year change-17.24%
  • Beta1.0581
Data delayed at least 15 minutes, as of Sep 19 2024 21:07 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of BRL
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments19,14314,76212,173
Total Receivables, Net4,7995,50810,316
Total Inventory12,53214,03016,335
Prepaid expenses----435
Other current assets, total96715834
Total current assets37,44134,45839,293
Property, plant & equipment, net42,22541,71640,005
Goodwill, net2,1732,0872,059
Intangibles, net935935818
Long term investments16514976
Note receivable - long term1,8722,0581,861
Other long term assets309720.05
Total assets91,74188,04992,564
LIABILITIES
Accounts payable13,22112,24712,053
Accrued expenses1,2151,3192,182
Notes payable/short-term debt000
Current portion long-term debt/capital leases3,7463,2912,165
Other current liabilities, total6,3127,3298,793
Total current liabilities24,49424,18525,194
Total long term debt53,67348,03748,397
Total debt57,41951,32850,562
Deferred income tax1,6771,1531,407
Minority interest(713)(1214)(1662)
Other liabilities, total8,6188,56511,362
Total liabilities87,74980,72784,699
SHAREHOLDERS EQUITY
Common stock8,0438,0438,043
Additional paid-in capital------
Retained earnings (accumulated deficit)(2738)1,8323,487
Treasury stock - common27(28)(38)
Unrealized gain (loss)------
Other equity, total(1340)(2525)(3627)
Total equity3,9927,3227,866
Total liabilities & shareholders' equity91,74188,04992,564
Total common shares outstanding797797796
Treasury shares - common primary issue0.000.670.90
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.